Skip to main content
. 2020 Dec 4;24(3):589–601. doi: 10.1007/s10120-020-01143-8

Table 1.

Clinical characteristics of ELISA cases

Pilot set Test set Korean set
Parameter Recurrence Non-recurrence Recurrence Non-recurrence Recurrence Non-recurrence
Age at surgery [years (range)] 60.7 (33–83) 67.1 (55–78) 63.6 (33–83) 64.13 (43–78) 53 (33–75) 60 (43–81)
Gender
 Male 8 10 28 21 3 17
 Female 3 3 8 10 3 5
Type II diabetes
 Y 0 1 4 4 1 3
 N 11 12 32 27 5 19
Tumour location
 Cardia 4 1 8 5 0 0
 Non cardia 7 12 28 26 6 22
H. pylori status
 Positive 6 6 19 17 2 3
 Negative 4 4 9 10 2 9
 Unknown 1 3 8 4 2 10
Chemo-radiotherapy
 Neo-Adjuvant
  No Adjuvant 9 13 33 30 6 22
  Adjuvant 2 0 3 1 0 0
 Adjuvant
  No Adjuvant 4 7 12 20 UNK UNK
  Adjuvant 7 6 24 11 UNK UNK
 Palliative
  No Palliative 3 N/A 19 N/A UNK N/A
  Palliative 8 N/A 13 N/A UNK N/A
  ND 0 N/A 4 N/A UNK N/A
 Pathology
  Diffuse 4 3 14 8 2 15
  Intestinal 6 8 12 20 3 7
  Mixed 1 0 7 1 1 0
  Adenocarcinoma 0 1 2 1 0 0
  Adenosquamous 0 1 1 1 0 0
 Differentiation
  Well 0 1 0 1 0 0
  Moderate 4 4 10 10 2 5
  Poor 6 6 20 18 3 13
  Undifferentiated 1 2 6 2 1 4
 T stage
  T1 0 2 0 7 0 0
  T2 3 4 5 11 0 1
  T3 8 7 29 13 1 8
  T4 0 0 2 0 5 13
 AJCC 6th stage
  IA 0 2 0 7 0 0
  IB 1 2 1 7 0 0
  II 3 5 10 9 0 0
  IIIA 5 2 16 4 0 4
  IIIB 1 2 3 4 1 5
  IV 1 0 6 0 5 13
Surgery type
 Proximal gastrectomy 3 1 6 1 0 0
 Distal gastrectomy 4 6 11 14 0 15
 Total gastrectomy 1 5 15 15 6 7
 Oesophagogastrectomy 3 1 4 1 0 0
Margins
 R0 11 12 32 30 4 22
 R1 0 1 4 1 2 0
Recurrence type
 Local 1 0 3 0 0 0
 Distant 5 0 22 0 5 0
 Both 5 0 11 0 1 0
 None 0 13 0 31 0 22
Time till recurrence 25.6 (5.9-43.5) N/A 21.1 (2.8-77.4) N/A 93 (30.6-233.23) N/A

N/A not applicable

UNK unknown